Demographics and disease characteristics of patients with psoriasis enrolled in the<scp>B</scp>ritish<scp>A</scp>ssociation of<scp>D</scp>ermatologists<scp>B</scp>iologic<scp>I</scp>nterventions<scp>R</scp>egister

Abstract

BADBIR is an invaluable resource to study the safety and effectiveness of both biologic and conventional systemic therapies. Understanding differences in baseline characteristics between cohorts is crucial in undertaking future pharmacovigilance studies.